- Home
- Products
- Customized ADCs
- FUT3
- Anti-FUT3-Mc-Dox ADC
Anti-FUT3-Mc-Dox ADC (CAT#: ADC-W-463)
This ADC product is comprised of an Anti-FUT3 antibody (clone BR 96) conjugated via a Mc linker to Dox. The Dox is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, Dox binds to DNA, causes DNA damage.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- BR 96
- Name
- FUT3
- Alternative Names
- FUT3; fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group); LE; Les; FT3B; CD174; FucT-III; galactoside 3(4)-L-fucosyltransferase; Lewis FT; fucosyltransferase III; alpha-(1,3/1,4)-fucosyltransferase; blood group Lewis alpha-4-f
- Target Entrez Gene ID
- 2525
- Target UniProt ID
- A8K737
- Overview
- The Lewis histo-blood group system comprises a set of fucosylated glycosphingolipids that are synthesized by exocrine epithelial cells and circulate in body fluids. The glycosphingolipids function in embryogenesis, tissue differentiation, tumor metastasis, inflammation, and bacterial adhesion. They are secondarily absorbed to red blood cells giving rise to their Lewis phenotype. This gene is a member of the fucosyltransferase family, which catalyzes the addition of fucose to precursor polysaccharides in the last step of Lewis antigen biosynthesis. It encodes an enzyme with alpha(1,3)-fucosyltransferase and alpha(1,4)-fucosyltransferase activities. Mutations in this gene are responsible for the majority of Lewis antigen-negative phenotypes. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene.
- Overview
- Chimeric Anti-FUT3 Antibody, clone # BR 96
- Clone #
- BR 96
- Species Reactivity
- Human
- Name
- Mc (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- Doxorubicin
- Description
- Doxorubicin is a type of anti-cancer chemotherapy drug called an anthracycline. Doxorubicin works by blocking an enzyme called TopoisomeraseⅡthat cancer cells need to divide and grow.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-LTA (Pateclizumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1535)
- Anti-CD33 (Lintuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-815)
- Anti-MSLN-Mc-VC-PABC-MMAE ADC-2 (CAT#: ADC-W-455)
- Anti-T-cell receptor (Maslimomab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1788)
- Anti-MUC1-CL2A-SN-38 ADC-1 (CAT#: ADC-W-594)
- Anti-NGF (Fulranumab)-MC-MMAF ADC (CAT#: ADC-W-1660)
- Anti-ERBB3 (Duligotumab)-MC-MMAF ADC (CAT#: ADC-W-2242)
- Anti-CD40 (Dacetuzumab)-SPDB-DM4 ADC (CAT#: ADC-W-897)
- Anti-AFP (Tacatuzumab)-SPDB-DM4 ADC (CAT#: ADC-W-657)
- Anti-C. diff Toxin A (Actoxumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2051)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-463. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-424 | Anti-FUT3-VC-MMAE ADC-1 | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-604 | Anti-FUT3-Mc-VC-PABC-MMAF ADC-3 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-459 | Anti-FUT3-AcBut-CalichDMH ADC-2 | AcBut [-(4' acetyl phenoxy) butanoic acid] | CalichDMH |
| ADC-W-423 | Anti-FUT3-hydrazone-doxorubicin ADC | hydrazone | doxorubicin |
| CAT# | Product Name | Linker | Payload |
| ADC-W-537 | Anti-TPBG-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-452 | Anti-CD70-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-517 | Anti-TM4SF1-Mc-LP2 ADC-1 | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
| ADC-W-478 | Anti-ENPP3-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-493 | Anti-CD19-Mc-MMAF ADC-3 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-578 | Anti-CD74-MCC-Dox ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | doxorubicin |
| ADC-W-479 | Anti-CD74-SMCC-Dox ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | Doxorubicin |
| ADC-W-503 | Anti-EGFR-EDC/NHS-Dox ADC | EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide) | Doxorubicin |
| ADC-W-339 | Anti-CD22-DIBO-doxorubicin ADC | DIBO (dibenzylcyclooctynol) | doxorubicin |
| ADC-W-600 | Anti-EGFR-doxorubicin ADC | polyethylene glycol linker | doxorubicin |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.